US Patent Issued to BIOINTERVENE on June 9 for "Adenosine analogs for the treatment of disease" (California, Florida, Massachusetts Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,740, issued on June 9, was assigned to BIOINTERVENE INC. (Atherton, Calif.).

"Adenosine analogs for the treatment of disease" was invented by Charles J. Cohen (Los Angeles), Arthur F. Kluge (Gainesville, Fla.), Soumya S. Ray (Quincy, Mass.) and John H. Hutchinson (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides adenosine analogs for the treatment of disease such as pain and inflammatory conditions."

The patent was filed on Feb. 15, 2023, under Application No. 18/169,321.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&...